For so many clinical studies to cure Alzheimer’s disease, here is one you wouldn’t believe is actually effective and has been studied by scientists in progress for couple of months now. This particular drug is actually from a herpes virus drug, and is assumed to treat Alzheimer’s disease.
According to Express UK, the primary experimental study ever to examine if the medications can have a result on the dreadful illness has been hurled at Umeå University in Sweden. Scientists at the university hurled the study after discovering a connection between the herpes virus infection and an augmented peril of Alzheimer's disease.
This study will be concluded for the next four weeks of progress. There were 36 people with Alzheimer's will obtain treatment with Valaciklovir, a medication which precisely targets active herpes type one virus which creates cold sores. Researchers will use brain imaging to observe the subjects, as well as a tracer substance which accrues in cells with active herpes virus infection.
In addition to this information in previous researches, according to Web MD: “Certain viral infections may increase the likelihood of mental decline and dementia, especially among older adults with heart disease. A new study shows that elderly people with evidence of infection with three common viruses -- viruses that cause cold sores, genital herpes, and a mono-like illness -- were more than twice as likely to suffer from dementia.”
They are foreseeing the two procedures will distinguish herpes virus infection in the brain cells of people with Alzheimer's. Their study comes after numerous preceding research which have found a positive link between the herpes virus and Alzheimer's. The latest came out in March this year subsequently in an international group of senior researchers and clinicians said there are two explicit types of bacteria and one virus - herpes type 1 - which causes Alzheimer's. Researchers are eager for the present study, the first of its kind, will prove the relation does exist and could indicate a main invention in a disease which has so far taken scientists to a dead-end.
This article is copyrighted by Travelers Today, the travel news leader
